The study of relationship between MTHFR C677T and ACE I/D variants and the risk of diabetic nephropathy in type 2 diabetes mellitus

Abstract

Background: In 30 to 40% of patients with type 2 diabetes mellitus (T2DM) nephropathy is developed. The aim of the present study was to find the synergistic effect of two polymorphisms of methylenetetrahydrofolate reductase (MTHFR) C677T and angiotensin converting enzyme insertion/ deletion (ACE I/D) polymorphism on the risk of diabetic nephropathy and its progression.